Sector: Pharmaceuticals & Biotechnology

Small Cap

Ishita Drugs & Ind Share Price

Ishita Drugs & Industries Ltd.

₹76.12

2.20(2.98%)

25th Jun 2026 | 3:12 PM

NSE :

Open Free Demat Account

Ishita Drugs & Ind Performance

Price Movement

N/A

₹70.40

₹85.00

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹85.00

Low₹70.40

Open at₹73.92

Prev Close₹73.92

Volumes17.01 K

Avg Price₹78.34

Lower Circuit₹60.91

Upper Circuit₹91.35

Historical Performance

3M High₹87.33

3M Low₹68.21

1 Yr High₹90.85

1 Yr Low₹66.00

3 Yr High₹104.75

3 Yr Low₹56.00

5 Yr High₹104.75

5 Yr Low₹27.25

Summary

As of 26-06-2026 03:04, Ishita Drugs & Industries Ltd. share price today is ₹0, with a change of ₹-73.92 (-100.00%) from the previous close of ₹73.92. The stock opened at ₹73.92 and traded between ₹70.4 and ₹85, with a total traded volume of 17014 shares. The company has a market capitalization of ₹22.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹90.85 and ₹66, respectively.

Ishita Drugs & Industries Ltd. valuation metrics include a P/E ratio of 29.2, and book value of ₹2.00. Profitability indicators show ROE of 6.72%. Ishita Drugs & Industries Ltd. has reported revenue of ₹14.66 Cr and net profit of ₹0.78 Cr.

Ishita Drugs & Industries Ltd. technical indicators include Day RSI at 49.93, Day MFI at 74.27, Day ADX at 15.25. Additional indicators include Commodity Channel Index (CCI) at 23.4 and Williams %R at -55.82. Momentum indicators show Day MACD at -1.12, Day MACD Signal Line at -1.15, DayATR at 5.57. Rate of Change indicators for Ishita Drugs & Industries Ltd. include ROC125 at 5.09 and ROC21 at -1.13.

Exponential moving averages include EMA5 at ₹74.8, EMA10 at ₹74.8, EMA12 at ₹75, EMA20 at ₹75.7, EMA26 at ₹76.1, EMA50 at ₹76.7, EMA100 at ₹76.3, EMA200 at ₹76.1. Simple moving averages include SMA5 at ₹73.9, SMA10 at ₹74.1, SMA20 at ₹76.1, SMA30 at ₹77.2, SMA50 at ₹78.2, SMA100 at ₹75.5, SMA150 at ₹74.9, SMA200 at ₹75.2.

Support levels for Ishita Drugs & Ind are placed at First Support ₹69.35, Second Support ₹62.58, Third Support ₹54.75. Resistance levels are seen at First Resistance ₹83.95, Second Resistance ₹91.78, Third Resistance ₹98.55. Ishita Drugs & Industries Ltd. shareholding pattern shows promoter holding at 50.04%, FII holding at 0%, DII holding at 0%, public holding at 49.97%.

Ishita Drugs & Ind Fundamentals

Market Cap

Low in industry

22.80 Cr.

PE Ratio (TTM)

Above industry Median

29.20

Dividend Yield

Net Profit TTM

10% decr over last year

0.78

Net Profit Growth

10% decr over last year

0.78

PEG Ratio

Negative PEG TTM

-2.80

ROE

16% decr over last year

6.72

Operating Revenue TTM

14.66

Operating Revenue Growth

2% decr over last year

Book Value

Below industry Median

MFI

MFI Overbought

74.27

RSI

RSI is mid-range

49.93

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

Ishita Drugs & Ind Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	3.06	3.14	3.07	5.40	4.56
Operating Expense	2.96	3	2.88	5.05	4.27
Operating Profit	0.09	0.14	0.19	0.35	0.29
Depreciation	0.02	0.03	0.03	0.03	0.03
Interest	0.02	0.02	0	0.02	0.04
Tax	0.10	0.04	0.08	0.08	0.09
Net Profit	0.18	0.16	0.14	0.30	0.29

Ishita Drugs & Ind Technicals

Ishita Drugs & Industries Ltd. EMA & SMA

₹76.12

2.20 (2.98%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹74.8

Day EMA10 ₹74.8

Day EMA12 ₹75

Day EMA20 ₹75.7

Day EMA26 ₹76.1

Day EMA50 ₹76.7

Day EMA100 ₹76.3

Day EMA200 ₹76.1

Ishita Drugs & Ind Support and Resistance

Resistance

First Resistance₹83.95

Second Resistance₹91.78

Third Resistance₹98.55

Support

First Support₹69.35

Second Support₹62.58

Third Support₹54.75

Technical Indicators

Day RSI49.93

Day MFI74.27

Day ADX15.25

Day Commodity Channel Index23.40

William-55.82

Day MACD-1.12

Day MACD Signal Line-1.15

Day ATR5.57

Day ROC1255.09

Day ROC21-1.13

Ishita Drugs & Ind Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	49.8	49.9	49.9	50	50	50
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	50.1	50.1	50.1	50	50	50

Ishita Drugs & Ind Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	7.93 K	17.01 K	46.59%
Week	2.74 K	4.61 K	59.32%
1 Month	1.12 K	1.71 K	65.35%
6 Month	1.28 K	1.65 K	77.47%

Ishita Drugs & Ind SWOT Analysis

Strengths14

Weakness6

Opportunity0

Threats0

MACD Crossover Above Signal Line

30 Day SMA crossing over 200 Day SMA, and current price greater than open

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing profits every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

MACD crossed above signal line previous end of day

Top Gainers

High Volume, High Gain

Volume Shockers

Ishita Drugs & Ind Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Ishita Drugs & Ind Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹43.20	₹588	₹201	₹258.80	₹35.50	₹5.70
% Change	-3.76%	-0.30%	-1.95%	-2.34%	-1.33%	-1.04%
Revenue TTM (₹ Cr)	-	-	-	-	₹1.27	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-0.25	₹-34.95
PE TTM	10.10	-	13.50	37.00	-84.00	-1.40
1 Year Return		49.31			688.89	471
ROCE	-	3.56	-	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 235.15

+0.73%

AMANTA

Amanta Healthcare Ltd.

₹ 162.00

-0.52%

AHCL

Anlon Healthcare Ltd.

₹ 16.37

+1.49%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 93.60

+1.15%

APL

Asston Pharmaceuticals Ltd.

₹ 81.00

-1.22%

UNICHEMLAB

Unichem Laboratories Ltd.

₹ 432.60

-0.22%

FERMENTA

Fermenta Biotech Ltd.

₹ 364.25

-0.26%

GENPHARMA

Genpharmasec Ltd.

₹ 1.11

-2.63%

KILITCH

Kilitch Drugs(I) Ltd.

₹ 185.00

-3.05%

MEDICO

Medico Remedies Ltd.

₹ 40.00

-2.56%

CONCORD

Concord Drugs Ltd.

₹ 76.40

+1.61%

PHARMAID

Pharmaids Pharmaceuticals Ltd.

₹ 36.00

+4.93%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 305.80

-1.61%

KIMIABL

Kimia Biosciences Ltd.

₹ 33.74

+4.88%

CORALAB

Coral Laboratories Ltd.

₹ 625.00

-3.52%

JENBURPH

Jenburkt Pharmaceuticals Ltd.

₹ 1126.60

-0.13%

KPL

Kwality Pharmaceuticals Ltd.

₹ 2436.70

-0.54%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 228.00

-0.61%

GVBL

Genomic Valley Biotech Ltd.

₹ 33.36

-4.98%

UNJHAFOR

Unjha Formulations Ltd.

₹ 19.00

+0.00%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.48

-0.52%

ANG

ANG Lifesciences India Ltd.

₹ 42.21

+1.93%

BROOKS

Brooks Laboratories Ltd.

₹ 73.20

-4.69%

FAQ's on ISHITADR

What is the Market Capitalization of Ishita Drugs & Industries Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ishita Drugs & Industries Ltd. is approximately ₹ 22.8 Cr.

What are the PE and PB ratios for Ishita Drugs & Industries Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ishita Drugs & Industries Ltd. is 29.2, and the Price-to-Book (PB) ratio is 2.

What is the 52-Week High and Low for Ishita Drugs & Industries Ltd.?

Over the past 52 weeks, the highest price reached by Ishita Drugs & Industries Ltd. shares was ₹ 90.85, and the lowest price was ₹ 66.

Who are the major shareholders of Ishita Drugs & Industries Ltd.?

Significant shareholdings in Ishita Drugs & Industries Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Ishita Drugs & Industries Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ishita Drugs & Industries Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy